Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 18 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Bizumentary to Premiere Sept. 24 Across National Networks
Beeline Holdings (NASDAQ: BLNE) announced that its “Bizumentary,” produced in partnership with Emmy Award-winning Loft…
-
QualityStocksNewsBreaks – Nocera, Inc. (NASDAQ: NCRA) Enters Worldwide Joint Distribution Agreement With E-PRO
Nocera (NASDAQ: NCRA) entered into a Strategic Partnership and Joint Distribution Agreement with Taiwan-based E-PRO…
-
QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Appoints Brian Goldenberg as Chief Financial Officer
Versus Systems (NASDAQ: VS) announced the appointment of Brian Goldenberg, CPA, as Chief Financial Officer,…